Catalyst Wire Dossier Catalyst Wire Dossier

Neo-MASCT immunotherapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neo-MASCT immunotherapy, covering 2017-07-05 to 2017-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Neo-MASCT Immunotherapy for Advanced NSCLC. [Phase 1, Phase 2]

See pricing